Rachele Frascatani
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
BRD4 contributes to the cytokine-induced acquisition of an IL-13RA2-positive inflammatory fibroblast phenotype.
Journal: Journal of Crohn's & colitis
Published: August 24, 2026
Acquired Loss of IL-10 Function in Inflammatory Bowel Disease.
Journal: Gastroenterology
Published: June 18, 2026
Crohn's Disease: From Immune Dysregulation to Intestinal Damage.
Journal: Inflammation
Published: April 23, 2026
Immunologic Drivers and Restraints in Colitis-Associated Colorectal Cancer.
Journal: Cancers
Published: March 24, 2026
Bromodomain-containing protein 4 in inflammatory diseases: molecular mechanisms and therapeutic potential.
Journal: Journal of inflammation (London, England)
Published: December 09, 2025
Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel Disease.
Journal: International journal of molecular sciences
Published: December 03, 2025
Bromodomain-containing 4 as a therapeutic target in inflammatory bowel diseases and colorectal cancer.
Journal: Frontiers in pharmacology
Published: August 08, 2025
Smad7 is a negative regulator of immunogenic cell death in colorectal cancer.
Journal: Oncoimmunology
Published: April 11, 2025
High Smad7 marks inflammation in patients with chronic pouchitis.
Journal: Frontiers in immunology
Published: December 20, 2024
Hepcidin Is a Valuable Therapeutic Target for Colorectal Cancer.
Journal: Cancers
Published: November 13, 2024
Last Updated: 09/26/2026